Navigation Links
Rosetta Genomics Reports Second Quarter 2008 Financial Results
Date:8/19/2008

ital

lease..................... 39 16

Deferred

revenue..................................... 228 228

Accrued severance

pay................................. 381 324

Total Long-term

Liabilities........................... 648 568

commitments and contingent liabilities

SHAREHOLDERS' EQUITY:

Share

capital:...................................... 27 27

Additional paid-in

capital............................... 59,503 58,984

Other comprehensive

income............................ (3) 86

Deferred stock-based

compensation....................... - -

Deficit accumulated during the development

stage............ (43,067) (35,492)

Total shareholders'

equity........................... 16,460 23,605

Total liabilities and shareholders'

equity............... $ 18,641 $ 26,038

---------------------------------

(1) American Cancer Society website, 2008 (2) Travis WD, Colby TV, Corrin B, et al.: Histological typing of lung and pleural tumours. 3rd ed. Berlin: Springer-Verlag, 1999.

Contact: Investors

Joshua Gordon, M.D.

T: +1-201-946-0561

E: investors@rosettagenomics.com

Media

Ron Kamienchick

T: +1-646-509-1893

E: media@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
2. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
3. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
4. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
5. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
6. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
7. /C O R R E C T I O N -- Rosetta Genomics Ltd/
8. Rosetta Genomics Reports First Quarter 2008 Financial Results
9. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
10. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
11. Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... World,s Top Gene Synthesis Compa...(IGSC) to Coordinate Best Practices in Risk Reduct...of Worldwide Gene Synthesis Capacity , ... the world’s leading gene synthesis companie... common screening protocol to promote biosecurity ...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswir...e program on one product candidate at an unexpecte...ate AD02 is planned to enter into,Phase II clinica...y,immediately follows the completion of two Phase ...mpany based its fast decision on the first interim...
(Date:11/18/2009)...ist at the National Institute of Standards and Tec...e, inexpensive method for detecting and measuring ...oxins, invisible spoilage in food or pesticides di...method is more sensitive than conventional techniq... are polarlike water molecules, having distinct el...
(Date:11/18/2009)...PAIGN, Ill. Imagine a polka-dotted postage stamp ...s simply by changing colors. , As reported in th..., Kenneth Suslick and his team at the University o...he general detection of toxic industrial chemicals...works by visualizing odors. This sensor array cou...
Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...et, Inc. (Nasdaq: VRUS ) announced today that th...ed with the FDA on the final design for a phase 2b...itis C (HCV), slated to initiate in the first quar...is advancing into a large phase 2b trial," stated ...al Officer. "R7128 is the most advanced nucleoside...
...me Sciences, Inc. (Nasdaq: HGSI ) announced toda...n Healthcare Conference will be webcast and may be...ww.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ) , ...ement team will present an overview of the company... Time (10:30 am Eastern Time). , , Investors inte...
...sia-FirstCall/ -- American Oriental,Bioengineering... leading marketer,distributor and manufacturer of ...oday commented on its recent purchase of buildings...velopment Area (BDA) for approximately $70.0,milli...ve Officer of AOBO, stated, "Our,recent property p...
Other Biology Technology:Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5American Oriental Bioengineering Comments on Recent Property Purchase 2American Oriental Bioengineering Comments on Recent Property Purchase 3
(Date:11/19/2009)...he offspring of two inbred strains tend to be supe...gene-level variability that leads to this phenomen...t our ability to custom-tailor crops for specific ...sumption or high glucose content for biomass fuel....ce of the common corn strain B73, University of Mi...
(Date:11/19/2009)...aize, also known as corn, researchers across the U...d pave the way to significant improvements in a pl...eed and fiber around the world. , The new map, a..., charts genetic diversity and recombination acros...arch team, led by U.S. Department of Agriculture s...
(Date:11/19/2009)...iana Tech University has found that a naturally oc...against giant salvinia. , Giant salvinia is a no... sunlight penetration into bodies of water, alteri...s been reported that giant salvinia can double in ...fessor of biological sciences at Louisiana Tech, s...
Breaking Biology News(10 mins):U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Microorganism may provide key to combating giant salvinia throughout Louisiana 2Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 1Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 2Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland 5299 1Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland 5299 2Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland 5299 3Genes signal late stage laryngeal cancer poorer outcome 59079 1Genes signal late stage laryngeal cancer poorer outcome 59079 2
...Breeding rice with higher levels of iron can have ...utrition, according to a new study in the Journal ...s from the Philippines and the United States, is a...iciency, one of the developing world,s most debili...cting nearly 2 billion people. , The lead authors ...
...Using tiny semiconductor crystals, biological prob... have developed a new method of finding specific s...microscope. , The researchers, who say the techni...demonstrated its potential in their lab by detecti... ovarian cancer. , The Johns Hopkins team describ...
...The stress a typical married couple feels during a...eir bodies, ability to heal from wounds by at leas...the couple,s relationship is routinely hostile tow...can be even doubled. The results of this study hav... and health care insurers. , The new study, repo...
Other Biology News:Study finds that nutritionally enhanced rice reduces iron deficiency 2Study finds that nutritionally enhanced rice reduces iron deficiency 3New nanosensor uses quantum dots to detect DNA 2Stress substantially slows human body's ability to heal 2Stress substantially slows human body's ability to heal 3
Equine IL-6, Unconjugated from R&D Systems
Feline IL-2, Unconjugated from R&D Systems
DALT GRADIENT MAKER,230V from GE Healthcare, formerly Amersham Biosciences
Cryopreservation Service from AbD Serotec
Biology Products: